Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV

Infect Immun. 2006 Aug;74(8):4910-4. doi: 10.1128/IAI.01860-05.

Abstract

In contrast to Yersinia pestis LcrV, the recombinant V10 (rV10) variant (lacking residues 271 to 300) does not suppress the release of proinflammatory cytokines by immune cells. Immunization with rV10 generates robust antibody responses that protect mice against bubonic plague and pneumonic plague, suggesting that rV10 may serve as an improved plague vaccine.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Antigens, Bacterial / administration & dosage
  • Antigens, Bacterial / genetics
  • Antigens, Bacterial / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Plague / immunology*
  • Plague / mortality
  • Plague / prevention & control*
  • Plague Vaccine / administration & dosage
  • Plague Vaccine / immunology*
  • Pore Forming Cytotoxic Proteins
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / immunology*
  • Vaccination
  • Yersinia pestis / immunology*

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • LcrV protein, Yersinia
  • Plague Vaccine
  • Pore Forming Cytotoxic Proteins
  • Recombinant Proteins